Quick Takeaways
- Deep Track Capital, LP filed SCHEDULE 13G for Bicara Therapeutics Inc. Common Stock, $0.0001 par value (BCAX).
- Disclosed ownership: 5%.
- Date of event: 05 Feb 2026.
Deep Track Capital, LP - 05 Feb 2026 SCHEDULE 13G Report for Bicara Therapeutics Inc. Common Stock, $0.0001 par value (BCAX)
- Filing Manager
- Deep Track Capital, LP
- Reporting Manager
- Deep Track Capital, LP
- Symbol
- BCAX
- Shares outstanding
- 54,780,876 shares
- Disclosed Ownership
- 2,750,000 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G
- Filing time
- 12 Feb 2026, 16:19:45 UTC
- Date of event
- 05 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Deep Track Capital, LP disclosed 5% ownership in Bicara Therapeutics Inc. Common Stock, $0.0001 par value (BCAX) on 05 Feb 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 Feb 2026, 16:19.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Deep Track Capital, LP | 5% | 2,750,000 | 0 | 2,750,000 | /s/ David Kroin | David Kroin, Managing Member of the General Partner of the Investment Adviser | |
| Deep Track Biotechnology Master Fund, Ltd. | 5% | 2,750,000 | 0 | 2,750,000 | /s/ David Kroin | David Kroin, Director | |
| David Kroin | 5% | 2,750,000 | 0 | 2,750,000 | /s/ David Kroin | David Kroin |